Article

Raremark Rebrands as Xperiome

Raremark has announced that it is rebranding as Xperiome. Jeremy Edwards, CEO of Xperiome, commented, “Strategically, we are rebranding because we have two very different audiences, with individual needs that will benefit from equal attention and focus.”

Xperiome will now become the name and corporate identity of the company, while the Raremark brand will solely represent its patient-facing activities dedicated to helping people better understand, talk about and manage rare diseases.

For more information, click here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Videos
© 2025 MJH Life Sciences

All rights reserved.